We are live on ! Find out more
EMB

Elefante Mark B Portfolio holdings

AUM $182M
1-Year Est. Return 17.71%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+17.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.4M
AUM Growth
+$1.33M
Cap. Flow
+$800K
Cap. Flow %
6.48%
Top 10 Hldgs %
46.66%
Holding
29
New
2
Increased
24
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$231K
2
ADI icon
Analog Devices
ADI
+$71.5K
3
CB icon
Chubb
CB
+$61.2K
4
UL icon
Unilever
UL
+$56.9K
5
DHR icon
Danaher
DHR
+$56.1K

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$231K
2
AAPL icon
Apple
AAPL
+$739

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.56%
3 Industrials 17.15%
4 Consumer Staples 10.33%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
1
Fiserv Inc
FISV
$28.8B
$699K 5.66%
11,430
+30
+0.3% +$1.81K
AAPL icon
2
Apple
AAPL
$4.54T
$658K 5.33%
18,236
-20
-0.1% -$739
MA icon
3
Mastercard
MA
$502B
$597K 4.83%
4,911
+70
+1% +$8.3K
PG icon
4
Procter & Gamble
PG
$336B
$586K 4.74%
6,715
+580
+9% +$51.1K
CB icon
5
Chubb
CB
$135B
$575K 4.66%
3,950
+435
+12% +$61.2K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.36T
$556K 4.5%
11,940
+280
+2% +$13.1K
JNJ icon
7
Johnson & Johnson
JNJ
$618B
$551K 4.46%
4,170
+40
+1% +$5.1K
MMM icon
8
3M
MMM
$90.9B
$525K 4.25%
3,018
+24
+0.8% +$4.01K
CVS icon
9
CVS Health
CVS
$133B
$515K 4.17%
6,400
+45
+0.7% +$3.55K
NVS icon
10
Novartis
NVS
$297B
$502K 4.06%
6,717
+446
+7% +$31.6K
RTX icon
11
RTX Corp
RTX
$290B
$498K 4.03%
6,475
+40
+0.6% +$3K
ADP icon
12
Automatic Data Processing
ADP
$106B
$488K 3.95%
4,761
+85
+2% +$8.6K
ABT icon
13
Abbott
ABT
$183B
$471K 3.81%
9,686
+895
+10% +$40.5K
UL icon
14
Unilever
UL
$137B
$449K 3.64%
7,373
+955
+15% +$56.9K
DHR icon
15
Danaher
DHR
$137B
$432K 3.5%
5,770
+750
+15% +$56.1K
ROK icon
16
Rockwell Automation
ROK
$53.4B
$426K 3.45%
2,630
+30
+1% +$4.73K
ATR icon
17
AptarGroup
ATR
$8.55B
$421K 3.41%
4,852
+135
+3% +$11.1K
XOM icon
18
ExxonMobil
XOM
$644B
$394K 3.19%
4,902
+140
+3% +$11.5K
CNI icon
19
Canadian National Railway
CNI
$76.9B
$376K 3.04%
4,642
+190
+4% +$14.5K
ADI icon
20
Analog Devices
ADI
$179B
$324K 2.62%
4,160
+900
+28% +$71.5K
XYL icon
21
Xylem
XYL
$27.3B
$293K 2.37%
5,286
+885
+20% +$46.1K
SLB icon
22
SLB Ltd
SLB
$73.6B
$255K 2.06%
3,855
+60
+2% +$4.3K
PEP icon
23
PepsiCo
PEP
$190B
$241K 1.95%
2,084
– –
XLNX
24
DELISTED
Xilinx Inc
XLNX
$235K 1.9%
+3,660
New +$231K
ILMN icon
25
Illumina
ILMN
$31B
$218K 1.76%
1,288
+46
+4% +$7.96K
1
2

Similar funds

CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
HWM
HFG Wealth Management The Woodlands, Texas $182M AUM 14.4% 1-Year Est. Return
AFS
Anderson Financial Strategies Dayton, Ohio $182M AUM 13.12% 1-Year Est. Return
TFP
Tilia Fiduciary Partners Wilmington, North Carolina $182M AUM 18.85% 1-Year Est. Return
CFG
Capital Financial Group Greenwood Village, Colorado $182M AUM
CFG
Cosner Financial Group Windsor, Colorado $182M AUM 12.93% 1-Year Est. Return
NED
Nancy E. Dempze $182M AUM 16.09% 1-Year Est. Return
RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return

Elefante Mark B's Q2 2017 Portfolio in Review

As of Q2 2017, Elefante Mark B held 29 positions worth $12.4M, up 12% from $11M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Elefante Mark B deployed $800K of net new capital in Q2 2017, opening 2 new positions and adding to 24 existing holdings. Its largest new stake was Xilinx Inc: 3,660 shares worth $235K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Apple, an estimated $739 trimmed.

  • Elefante Mark B's largest Q2 2017 buy was Xilinx Inc: 3,660 shares worth $235K.
  • Elefante Mark B added most to Analog Devices in Q2 2017, an estimated $71.5K increase.
  • Elefante Mark B's biggest Q2 2017 reduction was Apple, cutting an estimated $739.
  • Elefante Mark B fully exited Oracle in Q2 2017, selling an estimated $231K.
  • Elefante Mark B's ten largest holdings make up 47% of its $12.4M portfolio in Q2 2017.
  • Elefante Mark B opened 2 new positions and closed 1 in Q2 2017.
  • Elefante Mark B's portfolio value rose 12% quarter-over-quarter to $12.4M.

Based on Elefante Mark B's 13F filing for Q2 2017, filed 26 Jul 2017.